Panacea Biotec has bagged additional order from United Nations International Children's Emergency Fund (UNICEF) for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth around $5.20 million (around Rs 44 crore) in Q3CY2025.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.